Beyar Rafael
Director, Rambam Health Care Campus, Haifa, Israel; Professor of Medicine & Biomedical Engineering, Women's Division - Dr Phillip & Sarah Gotlieb Chair, Technion, Haifa, Israel; Chairman of the Steering Committee of the Israel National Transplantation center, Ministry of Health, Tel Aviv, Israel.
Rambam Maimonides Med J. 2011 Apr 30;2(2):e0049. doi: 10.5041/RMMJ.10049. Print 2011 Apr.
Organ transplantation has progressed tremendously with improvements in surgical methods, organ preservation, and pharmaco-immunologic therapies and has become a critical pathway in the management of severe organ failure worldwide. The major sources of organs are deceased donors after brain death; however, a substantial number of organs come from live donations, and a significant number can also be obtained from non-heart-beating donors. Yet, despite progress in medical, pharmacologic, and surgical techniques, the shortage of organs is a worldwide problem that needs to be addressed internationally at the highest possible levels. This particular field involves medical ethics, religion, and society behavior and beliefs. Some of the critical ethical issues that require aggressive interference are organ trafficking, payments for organs, and the delicate balance in live donations between the benefit to the recipient and the possible harm to the donor and others. A major issue in organ transplantation is the definition of death and particularly brain death. Another major critical factor is the internal tendency of a specific society to donate organs. In the review below, we will discuss the various challenges that face organ donation worldwide, and particularly in Israel, and some proposed mechanisms to overcome this difficulty.
随着手术方法、器官保存及药物免疫治疗的改进,器官移植取得了巨大进展,已成为全球重症器官衰竭治疗的关键途径。器官的主要来源是脑死亡后的死者捐赠者;然而,相当数量的器官来自活体捐赠,也有相当数量可从非心脏跳动捐赠者处获得。尽管医学、药理学和外科技术取得了进步,但器官短缺仍是一个全球性问题,需要在尽可能高的国际层面加以解决。这一特殊领域涉及医学伦理、宗教以及社会行为和信仰。一些需要积极干预的关键伦理问题包括器官买卖、器官交易以及活体捐赠中受赠者利益与对捐赠者及他人可能造成的伤害之间的微妙平衡。器官移植中的一个主要问题是死亡的定义,尤其是脑死亡。另一个主要关键因素是特定社会内部捐赠器官的倾向。在以下综述中,我们将讨论全球尤其是以色列在器官捐赠方面面临的各种挑战,以及一些为克服这一困难而提出的机制。